ENAM
geneOn this page
Summary
ENAM (enamelin, HGNC:3344) is a protein-coding gene on chromosome 4q13.3, encoding Enamelin (Q9NRM1). Involved in the mineralization and structural organization of enamel.
Dental enamel forms the outer cap of teeth and is the hardest substance found in vertebrates. This gene encodes the largest protein in the enamel matrix of developing teeth. The protein is involved in the mineralization and structural organization of enamel. Defects in this gene result in amelogenesis imperfect type 1C.
Source: NCBI Gene 10117 — RefSeq curated summary.
At a glance
- Gene–disease (curated): amelogenesis imperfecta type 1B (Definitive, GenCC) — +2 more curated relationships
- GWAS associations: 1
- Clinical variants (ClinVar): 305 total — 8 pathogenic, 3 likely-pathogenic
- Phenotypes (HPO): 7
- MANE Select transcript:
NM_031889
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:3344 |
| Approved symbol | ENAM |
| Name | enamelin |
| Location | 4q13.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000132464 |
| Ensembl biotype | protein_coding |
| OMIM | 606585 |
| Entrez | 10117 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000396073, ENST00000472597
RefSeq mRNA: 1 — MANE Select: NM_031889
NM_031889
CCDS: CCDS3544
Canonical transcript exons
ENST00000396073 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000850995 | 70642015 | 70646824 |
| ENSE00000904382 | 70631670 | 70631738 |
| ENSE00000904383 | 70631849 | 70631893 |
| ENSE00000904384 | 70632651 | 70632692 |
| ENSE00000904385 | 70634308 | 70634568 |
| ENSE00000904386 | 70635832 | 70635894 |
| ENSE00000904387 | 70637790 | 70637843 |
| ENSE00001523768 | 70629441 | 70629554 |
| ENSE00001523770 | 70628744 | 70628964 |
Expression profiles
Bgee: expression breadth broad, 83 present calls, max score 89.87.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1428 / max 16.4209, expressed in 56 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 47988 | 0.1428 | 56 |
Top tissues by expression
209 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left ventricle myocardium | UBERON:0006566 | 89.87 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 89.06 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 85.45 | gold quality |
| kidney epithelium | UBERON:0004819 | 83.73 | silver quality |
| islet of Langerhans | UBERON:0000006 | 81.84 | gold quality |
| vastus lateralis | UBERON:0001379 | 76.01 | silver quality |
| quadriceps femoris | UBERON:0001377 | 75.34 | silver quality |
| epithelial cell of pancreas | CL:0000083 | 74.13 | gold quality |
| biceps brachii | UBERON:0001507 | 72.94 | silver quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 72.51 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 72.30 | gold quality |
| muscle tissue | UBERON:0002385 | 71.99 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 71.69 | gold quality |
| deltoid | UBERON:0001476 | 69.72 | silver quality |
| corpus epididymis | UBERON:0004359 | 69.07 | gold quality |
| kidney | UBERON:0002113 | 69.03 | gold quality |
| buccal mucosa cell | CL:0002336 | 68.67 | gold quality |
| pancreas | UBERON:0001264 | 68.10 | gold quality |
| colonic epithelium | UBERON:0000397 | 67.47 | silver quality |
| gall bladder | UBERON:0002110 | 67.40 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 66.77 | gold quality |
| superficial temporal artery | UBERON:0001614 | 66.53 | gold quality |
| heart right ventricle | UBERON:0002080 | 66.20 | gold quality |
| gingival epithelium | UBERON:0001949 | 65.97 | gold quality |
| muscle of leg | UBERON:0001383 | 65.75 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 65.70 | silver quality |
| gastrocnemius | UBERON:0001388 | 65.47 | gold quality |
| heart left ventricle | UBERON:0002084 | 65.45 | gold quality |
| cardiac ventricle | UBERON:0002082 | 65.44 | gold quality |
| cortex of kidney | UBERON:0001225 | 64.94 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.13 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): CTNNB1, LEF1, SP3
miRNA regulators (miRDB)
115 targeting ENAM, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4510 | 100.00 | 66.60 | 2050 |
| HSA-MIR-6127 | 100.00 | 66.76 | 2188 |
| HSA-MIR-6129 | 100.00 | 66.46 | 2080 |
| HSA-MIR-6130 | 100.00 | 66.69 | 2012 |
| HSA-MIR-6133 | 100.00 | 66.48 | 2064 |
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-6077 | 99.99 | 68.04 | 2299 |
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-34A-5P | 99.99 | 71.21 | 1784 |
| HSA-MIR-449A | 99.99 | 71.05 | 1776 |
| HSA-MIR-4500 | 99.99 | 72.72 | 2367 |
| HSA-LET-7F-2-3P | 99.98 | 70.98 | 2588 |
| HSA-MIR-1185-1-3P | 99.98 | 71.04 | 2593 |
| HSA-MIR-1185-2-3P | 99.98 | 71.04 | 2593 |
| HSA-MIR-548P | 99.98 | 72.25 | 3784 |
| HSA-LET-7A-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7B-5P | 99.98 | 72.31 | 1790 |
| HSA-LET-7C-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7E-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7F-5P | 99.98 | 72.56 | 1784 |
| HSA-LET-7G-5P | 99.98 | 72.37 | 1784 |
| HSA-LET-7I-5P | 99.98 | 72.37 | 1788 |
| HSA-MIR-98-5P | 99.98 | 72.33 | 1787 |
| HSA-MIR-34C-5P | 99.97 | 70.45 | 1577 |
| HSA-MIR-449B-5P | 99.97 | 70.26 | 1580 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-3688-3P | 99.97 | 72.02 | 2834 |
| HSA-MIR-2110 | 99.96 | 66.68 | 1930 |
| HSA-MIR-548AT-5P | 99.96 | 70.83 | 2666 |
Literature-anchored findings (GeneRIF, showing 32)
- A nonsense mutation in the enamelin gene causes local hypoplastic autosomal dominant amelogenesis imperfecta (PMID:11978766)
- heterogeneous mutations are responsible for an autosomal-dominant hypoplastic form of amelogenesis imperfecta (PMID:12407086)
- critical for proper dental enamel formation (PMID:14656895)
- Demonstration of a ENAM mutation responsible for autosomal recessive amelogenesis imperfecta and localised enamel pitting. (PMID:14684688)
- Ultrastructural enamel changes in the patient with the autosomal dominant ENAM g.13185-13186insAG mutation, were less pronounced compared to ultrastructural changes in patients with the autosomal dominant ENAM mutation 8344delG. (PMID:17125728)
- A mutation was found in exon 9 where guanine was substituted by thymine in one of the alleles in position 817, generating a change of arginine to methionine in codon 179 of the protein. (PMID:17316551)
- This work shows that bursts of adaptive enamelin evolution occur on primate lineages with inferred dietary changes. (PMID:18245370)
- a single base difference g359A –> G located in exon 1 was identified and ruled out the possible mutation in exon 2, exon 3, exon 4, exon 5, exon 6, exon 7, exon 8, exon 9, exon 10, g2382, g6395 and g8344 of ENAM gene in the AI patient. (PMID:18466877)
- A total of 463 individuals from 54 families were evaluated and mutations in the AMEL, ENAM and KLK4 genes were identified. (PMID:18714142)
- Analysis revealed 2 ENAM mutations (autosomal-dominant g.14917delT and autosomal-recessive g.13185-13186insAG mutations). Single T deletion in exon 10 is a novel deletion mutation(g.14917delT, c.2991delT)predicted to result in premature termination codon. (PMID:19329462)
- The structure and composition of deciduous enamel affected by local hypoplastic autosomal dominant amelogenesis imperfecta resulting from an ENAM mutation (PMID:19923784)
- hypocalcified amelogenesis imperfecta, Witkop type III, was unrelated to previously described mutations in the ENAM or MMP-20 genes (PMID:21504268)
- Mutations in FAM83H and ENAM and related phenotypes were observed in Chinese families with amelogenesis imperfecta. (PMID:22414746)
- Associations between TFIP11 (p=0.02), ENAM (p=0.00001), and AMELX (p=0.01) could be seen with caries independent of having MIH or genomic DNA copies of Streptococcus mutans detected by real time PCR in the Brazilian sample. (PMID:23790503)
- 2 exonic SNPs, both changing an amino acid in protein region encoded by exon 10 (p.I648T and p.R763Q), increased caries susceptibility 2.66-fold. findings support ENAM as gene candidate for caries susceptibility. (PMID:24487377)
- Whole-exome sequencing identified 2 novel heterozygous nonsense mutations in the ENAM gene (c.454G>T p.Glu152* in family 1, c.358C>T p.Gln120* in family 2) in the probands. Affected individuals were heterozygous for the mutation in each family. (PMID:25143514)
- findings provide useful information for the implication of ENAM gene polymorphism in autosomal-dominant/-recessive amelogenesis imperfecta. (PMID:25427323)
- Screening of ENAM and LAMB3 genes was performed by direct sequencing of genomic DNA from blood samples. (PMID:25769099)
- Overrepresentation of the G allele of the enamelin marker was seen in the erosion group compared to the unaffected group. (PMID:25791822)
- The study revealed the strong association between rs12640848 marker of ENAM gene and caries susceptibility in primary teeth in children from Poland. (PMID:26910531)
- study investigated the phenotypic effect of SNP C14625T (rs7671281) on the thickness of human dental enamel, exploring the effects of positive selection on a dental gene (PMID:27357321)
- The ENAM and TNF-alpha genes were likely associated with caries occurrence in Chinese children. The ENAM rs3796703 CT and TNF-alpha rs1800629 AG genotypes might be involved in caries susceptibility and protection, respectively. (PMID:28395167)
- Among the variants shared with modern humans, two are ancestral (common with apes) and one is the derived enamelin major variant, T648I (rs7671281), associated with a thinner enamel and specific to the Homo lineage. (PMID:28902892)
- Lack of association between the ENAM polymorphism (rs12640848) and dental caries in Czech children was detected. (PMID:29185146)
- An ENAM nonsense mutation identified in a family with hypoplastic amelogenesis imperfecta resulted in a highly variable clinical phenotype in individuals with a heterozygous mutant allele. (PMID:29554435)
- Two novel ENAM frameshift mutations were identified. A single-nucleotide duplication replaced amino acids 133-1142 with a 12 amino acid sequence, and a single-nucleotide deletion replaced amino acids 921-1142 with 31 amino acids (ESSPQQASYQAKETAQRRGKAKTLLEMMCPR*). (PMID:31478359)
- ENAM Gene Variation in Students Exposed to Different Fluoride Concentrations. (PMID:32178265)
- ENAM gene associated with T classification and inhibits proliferation in renal clear cell carcinoma. (PMID:33539322)
- A novel ENAM mutation causes hypoplastic amelogenesis imperfecta. (PMID:33864320)
- Splicing mutations in AMELX and ENAM cause amelogenesis imperfecta. (PMID:37985977)
- Genetic variations in exon 10 of ENAM and their association with early childhood caries. (PMID:38642606)
- ENAM Mutations Can Cause Hypomaturation Amelogenesis Imperfecta. (PMID:38716742)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Enam | ENSMUSG00000029286 |
| rattus_norvegicus | Enam | ENSRNOG00000003672 |
Protein
Protein identifiers
Enamelin — Q9NRM1 (reviewed: Q9NRM1)
All UniProt accessions (2): Q9NRM1, A0A3B3ITB9
UniProt curated annotations — full annotation on UniProt →
Function. Involved in the mineralization and structural organization of enamel. Involved in the extension of enamel during the secretory stage of dental enamel formation.
Subcellular location. Secreted. Extracellular space. Extracellular matrix.
Tissue specificity. Expressed in tooth particularly in odontoblast, ameloblast and cementoblast.
Post-translational modifications. Phosphorylated by FAM20C in vitro.
Disease relevance. Amelogenesis imperfecta 1B (AI1B) [MIM:104500] An autosomal dominant defect of enamel formation. Clinical manifestations may be variable. Some cases present with generalized enamel hypoplasia resulting in small, smooth, yellow and widely spaced teeth (smooth hypoplastic AI). Others show horizontal rows of pits, grooves or a hypoplastic area in the enamel (local hypoplastic AI). The disease is caused by variants affecting the gene represented in this entry. Amelogenesis imperfecta 1C (AI1C) [MIM:204650] An autosomal recessive defect of dental enamel formation. Teeth show local hypoplastic and unmineralized enamel, and a yellow-brown discoloration. Enamel defects can be associated with facial and oral features including vertical dysgnathia and anterior openbite malocclusion. The disease is caused by variants affecting the gene represented in this entry.
RefSeq proteins (1): NP_114095* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR015673 | Enamelin | Family |
Pfam: PF15362
UniProt features (45 total): compositionally biased region 15, glycosylation site 10, region of interest 6, sequence variant 6, sequence conflict 3, modified residue 2, signal peptide 1, chain 1, mutagenesis site 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9NRM1-F1 | 36.63 | 0.00 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 191, 216
Glycosylation sites (10): 114, 126, 245, 252, 265, 296, 467, 534, 934, 1040
Mutagenesis-validated functional residues (1):
| Position | Phenotype |
|---|---|
| 191 | decreased phosphorylation by fam20c. |
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-381426 | Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| R-HSA-8957275 | Post-translational protein phosphorylation |
MSigDB gene sets: 110 (showing top):
GOBP_EPITHELIUM_DEVELOPMENT, GOBP_TOOTH_MINERALIZATION, chr4q13, GOBP_ANIMAL_ORGAN_MORPHOGENESIS, GOBP_ENAMEL_MINERALIZATION, GOMF_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT, WTGAAAT_UNKNOWN, GOBP_AMELOGENESIS, GOBP_COLUMNAR_CUBOIDAL_EPITHELIAL_CELL_DIFFERENTIATION, POU3F2_02, GOBP_ODONTOGENESIS_OF_DENTIN_CONTAINING_TOOTH, GOBP_POSITIVE_REGULATION_OF_DEVELOPMENTAL_PROCESS, GOBP_ODONTOGENESIS, GOCC_ENDOPLASMIC_RETICULUM_LUMEN, YATGNWAAT_OCT_C
GO Biological Process (4): biomineral tissue development (GO:0031214), ameloblast differentiation (GO:0036305), positive regulation of enamel mineralization (GO:0070175), amelogenesis (GO:0097186)
GO Molecular Function (2): structural constituent of tooth enamel (GO:0030345), protein binding (GO:0005515)
GO Cellular Component (3): endoplasmic reticulum lumen (GO:0005788), extracellular matrix (GO:0031012), extracellular region (GO:0005576)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Metabolism of proteins | 1 |
| Post-translational protein modification | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| tissue development | 1 |
| animal organ development | 1 |
| columnar/cuboidal epithelial cell differentiation | 1 |
| enamel mineralization | 1 |
| positive regulation of tooth mineralization | 1 |
| regulation of enamel mineralization | 1 |
| odontogenesis of dentin-containing tooth | 1 |
| anatomical structure formation involved in morphogenesis | 1 |
| extracellular matrix structural constituent conferring compression resistance | 1 |
| binding | 1 |
| endoplasmic reticulum | 1 |
| intracellular organelle lumen | 1 |
| external encapsulating structure | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
990 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ENAM | AMBN | Q9NP70 | 999 |
| ENAM | AMTN | Q6UX39 | 993 |
| ENAM | AMELX | Q99217 | 985 |
| ENAM | TUFT1 | Q9NNX1 | 981 |
| ENAM | DSPP | Q9NZW4 | 899 |
| ENAM | MMP20 | O60882 | 888 |
| ENAM | ODAM | A1E959 | 855 |
| ENAM | KLK4 | Q9Y5K2 | 836 |
| ENAM | SACK1H | Q6ZRV2 | 811 |
| ENAM | AMELY | Q99218 | 798 |
| ENAM | WDR72 | Q3MJ13 | 788 |
| ENAM | ODAPH | Q17RF5 | 773 |
| ENAM | ACP4 | Q9BZG2 | 717 |
| ENAM | MMP25 | Q9NPA2 | 717 |
| ENAM | DMP1 | Q13316 | 710 |
IntAct
5 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| FAM20C | ENAM | psi-mi:“MI:0217”(phosphorylation reaction) | 0.440 |
| ENAM | FAM20C | psi-mi:“MI:0217”(phosphorylation reaction) | 0.440 |
| ENAM | NCL | psi-mi:“MI:0915”(physical association) | 0.400 |
| NEK4 | E2F8 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (6): ENAM (Proximity Label-MS), ENAM (Affinity Capture-MS), ENAM (Affinity Capture-MS), ENAM (Cross-Linking-MS (XL-MS)), ENAM (Proximity Label-MS), ENAM (Affinity Capture-RNA)
ESM2 similar proteins: A0A0J9YXV3, A0A172M4N0, A2VE23, A5PL33, C7EMF5, E7EW31, F1NSM7, I3L273, O15027, O48582, O55189, O55196, O97939, P0C671, P0DV77, P14138, Q14D33, Q1XI13, Q28989, Q3B7M4, Q4R729, Q5R7U0, Q5SWP3, Q62840, Q63003, Q6E0U4, Q6H236, Q6NUN9, Q6UXA7, Q7Z2K8, Q86UU5, Q8BM15, Q8K4E0, Q8K4L6, Q8N1P7, Q8N3D4, Q96D09, Q96JG9, Q9BGL9, Q9D7G9
Diamond homologs: O55196, O97939, Q9NRM1
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
305 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 8 |
| Likely pathogenic | 3 |
| Uncertain significance | 231 |
| Likely benign | 22 |
| Benign | 25 |
Top pathogenic / likely-pathogenic (11)
| Variant ID | HGVS | Classification |
|---|---|---|
| 1012267 | NM_031889.3(ENAM):c.-61+1G>A | Pathogenic |
| 1192504 | NM_031889.3(ENAM):c.588+1del | Pathogenic |
| 2445233 | NM_031889.3(ENAM):c.664C>T (p.Gln222Ter) | Pathogenic |
| 4236 | NM_031889.3(ENAM):c.534+1G>A | Pathogenic |
| 4237 | NM_031889.3(ENAM):c.157A>T (p.Lys53Ter) | Pathogenic |
| 4813874 | NM_031889.3(ENAM):c.1083G>A (p.Trp361Ter) | Pathogenic |
| 488662 | NM_031889.3(ENAM):c.1842C>G (p.Tyr614Ter) | Pathogenic |
| 517662 | NM_031889.3(ENAM):c.123+2T>G | Pathogenic |
| 2440040 | NM_031889.3(ENAM):c.372_382del (p.Lys124fs) | Likely pathogenic |
| 2628824 | NM_031889.3(ENAM):c.107del (p.Asn36fs) | Likely pathogenic |
| 2690595 | NM_031889.3(ENAM):c.935_944del (p.Ser312fs) | Likely pathogenic |
SpliceAI
989 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 4:70631735:GCCA:G | donor_gain | 1.0000 |
| 4:70631739:G:GG | donor_gain | 1.0000 |
| 4:70632645:TTGCA:T | acceptor_loss | 1.0000 |
| 4:70632646:TGCA:T | acceptor_loss | 1.0000 |
| 4:70632647:GCA:G | acceptor_loss | 1.0000 |
| 4:70632648:CA:C | acceptor_loss | 1.0000 |
| 4:70632649:A:AG | acceptor_gain | 1.0000 |
| 4:70632649:AGAT:A | acceptor_gain | 1.0000 |
| 4:70632650:G:GG | acceptor_gain | 1.0000 |
| 4:70632650:GAT:G | acceptor_gain | 1.0000 |
| 4:70632650:GATG:G | acceptor_gain | 1.0000 |
| 4:70632690:CATGT:C | donor_loss | 1.0000 |
| 4:70632693:G:GG | donor_gain | 1.0000 |
| 4:70632693:GTAA:G | donor_loss | 1.0000 |
| 4:70632694:T:TC | donor_loss | 1.0000 |
| 4:70632695:AAGT:A | donor_loss | 1.0000 |
| 4:70634303:TTCA:T | acceptor_loss | 1.0000 |
| 4:70634306:A:AG | acceptor_gain | 1.0000 |
| 4:70634306:A:T | acceptor_loss | 1.0000 |
| 4:70634306:AGAT:A | acceptor_gain | 1.0000 |
| 4:70634307:G:GA | acceptor_loss | 1.0000 |
| 4:70634307:G:GG | acceptor_gain | 1.0000 |
| 4:70634307:GAT:G | acceptor_gain | 1.0000 |
| 4:70634307:GATG:G | acceptor_gain | 1.0000 |
| 4:70635826:CTCTA:C | acceptor_loss | 1.0000 |
| 4:70635827:TCTAG:T | acceptor_loss | 1.0000 |
| 4:70635828:CTAGG:C | acceptor_loss | 1.0000 |
| 4:70635829:TAG:T | acceptor_loss | 1.0000 |
| 4:70635830:A:AG | acceptor_gain | 1.0000 |
| 4:70635830:A:G | acceptor_loss | 1.0000 |
AlphaMissense
7576 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 4:70631879:A:C | S52R | 0.987 |
| 4:70631881:T:A | S52R | 0.987 |
| 4:70631881:T:G | S52R | 0.987 |
| 4:70631885:A:C | S54R | 0.987 |
| 4:70631887:T:A | S54R | 0.987 |
| 4:70631887:T:G | S54R | 0.987 |
| 4:70631873:T:C | F50L | 0.986 |
| 4:70631875:T:A | F50L | 0.986 |
| 4:70631875:T:G | F50L | 0.986 |
| 4:70631892:A:T | E56V | 0.980 |
| 4:70631889:A:T | E55V | 0.978 |
| 4:70637826:A:C | S191R | 0.978 |
| 4:70637828:C:A | S191R | 0.978 |
| 4:70637828:C:G | S191R | 0.978 |
| 4:70642024:T:C | F200L | 0.976 |
| 4:70642026:T:A | F200L | 0.976 |
| 4:70642026:T:G | F200L | 0.976 |
| 4:70631891:G:A | E56K | 0.975 |
| 4:70631886:G:T | S54I | 0.968 |
| 4:70631883:A:T | K53I | 0.967 |
| 4:70631880:G:T | S52I | 0.965 |
| 4:70642057:C:A | R211S | 0.963 |
| 4:70642033:T:C | F203L | 0.959 |
| 4:70642035:T:A | F203L | 0.959 |
| 4:70642035:T:G | F203L | 0.959 |
| 4:70642084:T:C | F220L | 0.959 |
| 4:70642086:T:A | F220L | 0.959 |
| 4:70642086:T:G | F220L | 0.959 |
| 4:70632669:T:C | F63L | 0.956 |
| 4:70632671:C:A | F63L | 0.956 |
dbSNP variants (sampled 300 via entrez): RS1000010635 (4:70627648 T>A), RS1000035921 (4:70631287 G>A), RS1000071270 (4:70627287 C>T), RS1000080815 (4:70626893 A>T), RS1000185100 (4:70641130 T>C), RS1000237270 (4:70641380 A>G,T), RS1000495167 (4:70645855 G>C), RS1000531546 (4:70634231 G>A,C,T), RS1000743168 (4:70627976 C>T), RS1000768767 (4:70646424 C>T), RS1001222404 (4:70646063 T>G), RS1001399631 (4:70633282 C>A), RS1001450653 (4:70630780 C>A,T), RS1001457515 (4:70640399 G>A), RS1001850986 (4:70632917 G>A)
Disease associations
OMIM: gene MIM:606585 | disease phenotypes: MIM:104500, MIM:204650
GenCC curated gene-disease
| Disease | Classification | Inheritance |
|---|---|---|
| amelogenesis imperfecta type 1B | Definitive | Autosomal dominant |
| amelogenesis imperfecta type 1C | Strong | Autosomal recessive |
| amelogenesis imperfecta type 1 | Strong | Semidominant |
Mondo (4): amelogenesis imperfecta (MONDO:0019507), amelogenesis imperfecta type 1B (MONDO:0007092), amelogenesis imperfecta type 1C (MONDO:0008770), amelogenesis imperfecta type 1 (MONDO:0015047)
Orphanet (1): Amelogenesis imperfecta (Orphanet:88661)
HPO phenotypes
7 total (7 of 7 shown, HPO-id order):
| HPO | Term |
|---|---|
| HP:0000006 | Autosomal dominant inheritance |
| HP:0000007 | Autosomal recessive inheritance |
| HP:0000679 | Taurodontia |
| HP:0000705 | Amelogenesis imperfecta |
| HP:0006285 | Enamel hypomineralization |
| HP:0006286 | Yellow-brown discoloration of the teeth |
| HP:0009102 | Anterior open-bite malocclusion |
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST009531_3 | Body fat percentage | 5.000000e-08 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007800 | body fat percentage |
MeSH disease descriptors (3)
| Descriptor | Name | Tree numbers |
|---|---|---|
| D000567 | Amelogenesis Imperfecta | C07.650.800.295.250; C07.793.700.295.250; C16.131.850.800.295.250 |
| C562879 | Amelogenesis Imperfecta, Type IB (supp.) | |
| C567147 | Amelogenesis Imperfecta, Type Ic (supp.) |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | affects cotreatment, increases methylation | 1 |
| cupric chloride | affects expression | 1 |
| Fulvestrant | affects cotreatment, increases methylation | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Doxorubicin | decreases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
8 trials via MONDO — disease-level, not drug-specific.
| Trial | Phase | Status | Title |
|---|---|---|---|
| NCT01746121 | Not specified | TERMINATED | Amelogenesis Imperfecta |
| NCT02994862 | Not specified | UNKNOWN | E. Max Laminate Veneers With and Without Using Galla Chinnesis as Natural Cross Linking and Remineralizing Agent |
| NCT03810859 | Not specified | UNKNOWN | Non-syndromic Inherited Anomalies of Mineralized Tooth Tissues: a Whole Exome Study to Identify New Pathogenic Variants |
| NCT04704089 | Not specified | RECRUITING | Colorimetric, Ultra-structural and Elemental Comparison of Dental Enamel Defects |
| NCT04897724 | Not specified | UNKNOWN | Clinical Performance of Composites in Patients With Amelogenesis Imperfecta |
| NCT04927962 | Not specified | COMPLETED | Psycho-social Impact of Amelogenesis and Dentinogenesis Imperfecta |
| NCT05343247 | Not specified | COMPLETED | Dental Age Estimation by Different Methods in Patients With Amelogenesis Imperfecta |
| NCT07250906 | Not specified | RECRUITING | Oral Health Related Quality of Life of Children With Amelogenesis Imperfecta |
Related Atlas pages
- Associated diseases: amelogenesis imperfecta type 1B, amelogenesis imperfecta type 1C, amelogenesis imperfecta type 1
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): amelogenesis imperfecta, amelogenesis imperfecta type 1, amelogenesis imperfecta type 1B, amelogenesis imperfecta type 1C